Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05714449 · ClinicalTrials.gov registry record · NA

OCT Eccentric Fixation and Amblyopia in Children

A NA study of Amblyopia, sponsored by State University of New York College of Optometry.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05714449: Recruiting NA study of Amblyopia, sponsored by State University of New York College of Optometry.

NCT05714449 is a NA study of Amblyopia that is actively recruiting participants, run by State University of New York College of Optometry. The registered enrollment target is 30 participants, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05714449, a NA study of Amblyopia, is actively recruiting participants, sponsored by State University of New York College of Optometry.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

Conditions Studied

Interventions

  • DEVICE eye patch
  • DEVICE After-image and MIT trainer

Study Locations (1)

New York

  • SUNY College of Optometry - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-01-25
Est. Completion 2026-01-24
Phase NA

What NCT05714449 shows while recruiting

NCT05714449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which eye patch is the first listed.

NCT05714449 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05714449 about?

NCT05714449 is a clinical study titled "OCT Eccentric Fixation and Amblyopia in Children". The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

What is the current status of trial NCT05714449?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-25. Estimated completion is 2026-01-24.

What conditions does trial NCT05714449 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT05714449?

The interventions under investigation include: eye patch (DEVICE), After-image and MIT trainer (DEVICE).

Who is sponsoring clinical trial NCT05714449?

This trial is sponsored by State University of New York College of Optometry, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05714449 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05714449's enrollment target sits among peer trials

30 21st of 24 higher than 3 of 24 other Amblyopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05714449, the US trial registry maintained by the National Library of Medicine. NCT05714449 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.